Gravol and Abraxane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gravol (dimenhydrinate) and Abraxane (paclitaxel). Common drug interactions include large intestinal obstruction among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Gravol and Abraxane. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Gravol?

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 7,192 Gravol users. Check the latest studies of Gravol.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

On Jul, 13, 2026

39 people who take Gravol and Abraxane together, and have interactions are studied.

What are the common drug interactions of Gravol and Abraxane, by gender? *:

female:

Large intestinal obstruction
Small intestinal perforation (hole in small intestine)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Death
Febrile neutropenia (fever with reduced white blood cells)
Full blood count decreased
Hypersensitivity
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Transaminases increased

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Oedema peripheral (superficial swelling)
Asthenia (weakness)
Diarrhoea
Hospitalisation
Muscular weakness (muscle weakness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Autoimmune hepatitis

What are the common drug interactions of Gravol and Abraxane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dyspnoea (difficult or laboured respiration)
Muscular weakness (muscle weakness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Large intestinal obstruction
Small intestinal perforation (hole in small intestine)
Asthenia (weakness)
Death
Diarrhoea
Gait disturbance

50-59:

Oedema peripheral (superficial swelling)
Autoimmune hepatitis
Hepatitis (inflammation of the liver)
Abdominal pain
Pyrexia (fever)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Death
Fatigue (feeling of tiredness)
Gait disturbance

60+:

Febrile neutropenia (fever with reduced white blood cells)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 26 people, 66.67%
Pancreatic Carcinoma (pancreatic cancer): 26 people, 66.67%
Abdominal Pain: 24 people, 61.54%
Indigestion: 21 people, 53.85%
Constipation: 19 people, 48.72%
Insomnia (sleeplessness): 19 people, 48.72%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 17 people, 43.59%
Diabetes: 13 people, 33.33%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 13 people, 33.33%
High Blood Pressure: 13 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gravol and Abraxane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously